Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases ...Middle East

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised $60 million in its...

Hence then, the article about alebund pharmaceuticals raises 60 million in series b financing round to accelerate its development of innovative drugs and total solutions for the treatment of renal diseases was published today ( Monday 10/05/2021 - 03:33 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases )

Also on site :

• A stillbirth and Facebook post expressing her grief landed her in prison for over 2 years. Experts say it’s part of a pattern
• The Dietitian-Approved Starbucks Matcha Order You Need To Try
• Dave Matthews Band Just Played a Secret Gig at Disney World’s Cinderella Castle—See the Video